Literature DB >> 7697839

Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis.

E Ludwig1, P S Corneli, J L Anderson, H W Marshall, J M Lalouel, R H Ward.   

Abstract

BACKGROUND: Although both genetic and nongenetic factors contribute to the pathogenesis of coronary artery disease, the identification of specific genetic lesions has lagged behind the identification of critical environmental risk factors. A reported association between myocardial infarction (MI) and the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene in European men suggests a critical role for this genomic region. However, the generality of this association remains to be determined. It also is not clear at what stage in disease progression the association with the ACE I/D polymorphism becomes important. METHODS AND
RESULTS: We evaluated the ACE I/D polymorphism in patients who had undergone coronary angiography (402 men and 295 women) and in 203 representative control subjects. After polymerase chain reaction amplification, genotypes were determined by agarose gel sizing and by hybridization with allele-specific oligonucleotides. After patients were categorized by the degree of coronary artery stenosis and the occurrence of an MI, the distribution of ACE I/D genotypes was evaluated by log linear analysis. Patients were genetically representative of the regional population, and patients with > 60% stenosis of their coronary arteries had the same distribution of ACE I/D genotypes as did patients with < 10% stenosis. However, among patients with stenosis, the occurrence of an MI was significantly associated with the D allele in all patients (odds ratio [OR], 1.59; P = .002) and in men alone (OR, 1.63; P = .006). The lack of significance in women (OR, 1.40; P = .263) is probably due to the fact that only 36 women in the present study had experienced an MI. Furthermore, the association between MI and the ACE I/D polymorphism was independent of blood pressure, smoking habits, and body mass index.
CONCLUSIONS: Segregation of the ACE I/D polymorphism is a pervasive genetic risk factor for MI in whites but has no evident effect on the events leading to stenosis of the coronary arteries. This suggests that risk of MI is influenced by two independent processes--atherogenesis that leads to coronary stenosis followed by conversion to MI. The renin-angiotensin system appears to confer significant risk of infarction by influencing the conversion to MI but has no apparent effect on the development of atherostenosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7697839     DOI: 10.1161/01.cir.91.8.2120

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  20 in total

1.  A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

Authors:  S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

2.  Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints.

Authors:  B D Horne; J L Anderson; J F Carlquist; J B Muhlestein; D G Renlund; T L Bair; R R Pearson; N J Camp
Journal:  Ann Hum Genet       Date:  2005-03       Impact factor: 1.670

3.  Is the inherited ACE genotype a trump or a joker?

Authors:  W E Mitch
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 4.  Should we aim at tissue renin-angiotensin systems?

Authors:  J F Smits; R C Passier; M J Daemen
Journal:  Pharm World Sci       Date:  1998-06

5.  Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.

Authors:  H Schunkert; H W Hense; M Muscholl; A Luchner; S Kürzinger; A H Danser; G A Riegger
Journal:  Heart       Date:  1997-01       Impact factor: 5.994

6.  Increased risk for ischaemic events is related to combined RAS polymorphism.

Authors:  P P van Geel; Y M Pinto; A H Zwinderman; R H Henning; A J van Boven; J W Jukema; A V Bruschke; J J Kastelein; W H van Gilst
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 7.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

8.  Genetical, histological, and clinical characteristics of IgA-negative mesangioproliferative glomerulopathy.

Authors:  Kazunori Owada; Hodaka Suzuki; Tetsuo Katoh; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2009-11-25       Impact factor: 2.801

9.  Angiotensin converting enzyme DD genotype is associated with development of rheumatic heart disease in Egyptian children.

Authors:  Mohamed-Mofeed Fawaz Morsy; Nada Abdelmohsen Mohamed Abdelaziz; Ahmed Mohamed Boghdady; Hydi Ahmed; Essam Mohamed Abu Elfadl; Mohamed Ali Ismail
Journal:  Rheumatol Int       Date:  2009-10-22       Impact factor: 2.631

10.  Angiotensin-converting enzyme gene polymorphism in hypertensive rural population of Haryana, India.

Authors:  Sumeet Gupta; Bimal K Agrawal; Rajesh K Goel; Prabodh K Sehajpal
Journal:  J Emerg Trauma Shock       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.